Recital 24

(24) Trading venues should be obliged to provide ESMA with identifying reference data for transparency purposes, including identifiers of OTC derivatives. The identifier currently used for derivatives, namely the ISIN, has proved cumbersome and ineffective for public transparency, and that situation should be remedied by using identifying reference data based on a globally agreed unique product identifier, such as the ISO 4914 Unique Product Identifier (UPI). The UPI has been developed as an identification tool for OTC derivative products, with the intention to bring increased transparency and aggregation of data across the global OTC derivative markets. However, it is possible that that unique identifier is not sufficient and that it needs to be complemented by additional identifying data. Therefore, the Commission should specify, by means of delegated acts, the identifying reference data to be used with regard to OTC derivatives, including a unique identifier and any other relevant identifying reference data. In relation to the identifier to be used for the purposes of transaction reporting pursuant to Regulation (EU) No 600/2014, the Commission should specify the most appropriate identifiers of OTC derivatives, which might be different from the identifier determined for transparency requirements, taking into account the different purposes of those requirements, in particular as regards supervision of market abuse by competent authorities.

← Recital 23 · All articles · Recital 25 →

Source: EUR-Lex (Cellar) · retrieved 2026-10-13 · Text as adopted (Official Journal); later amendments are not incorporated in this text.